Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07182110 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dexamethasone-Enhanced TAP Block in Lapchole

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2025 (before its estimated August 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The transversus abdominis plane (TAP) block is widely used as part of analgesia for abdominal surgeries such as laparoscopic cholecystectomy. While bupivacaine is commonly used for TAP blocks with reported success. Dexamethasone is often used as an adjuvant in prolonging duration of blocks; however, data on its efficacy in enhancing TAP blocks in laparoscopic cholecystectomy remain limited. This study aims to assess whether adding dexamethasone to bupivacaine in a TAP block improves postoperative pain control and reduces opioid consumption
Trial Details
NCT Number NCT07182110
Lead Sponsor Makassed General Hospital
Conditions
(from sponsor)		 Laparoscopic Cholecystectomy
Related terms Acute Pain, Agnosia, Breakthrough Pain, Pain
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov